Experience across emerging and large Pharma, Biotech, OTC and HealthTech
Robert Molander is a global healthcare leader, board member, and consultant, bringing over 25 years of expertise in driving transformative growth across the pharmaceutical, biotech, OTC, and healthtech industries.
With a successful track record at industry giants like Novartis, Pfizer, and Shionogi, as well as in the healthtech sector through Trialbee, Robert founded Stratfox Healthcare Group LLC to provide targeted solutions to small and mid-sized pharma and biotech companies, private equity firms, and investment banks in the U.S. and Europe.
His commitment to enabling healthcare commercialization has inspired Robert to become a board member of publicly listed Xspray AB, SciBase AB, Biosergen AB (current) and Infant Bacterial Therapeutics AB (past) and servicing a variety of strategic engagements. Some examples include identifying and launching >$300M in growth initiatives for a major US Oncology organization, developing a US Market Access Hemophilia Roadmap for a European mid-size specialty pharmaceutical firm, building an Operational Marketing Planning Framework for a major global pharmaceutical organization and providing a US investment firm with strategic assessment on the underwriting of debt for a commercial stage pharmaceutical asset.